Clinical Trial Update: The TRANQUILITY 2 Trial: A Phase 3 Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease [Phase 3]

View source ↗

Summary

The TRANQUILITY 2 Phase 3 trial for Dry Eye Disease has completed and its results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Snippet

Sponsor: Aldeyra Therapeutics, Inc. | Conditions: Dry Eye | Phase 3 | Status: COMPLETED | Results posted: 2025-03-18